Chandler, AZ9 Active Studies

Rheumatoid Arthritis Clinical Trials in Chandler, AZ

Find 9 actively recruiting rheumatoid arthritis clinical trials in Chandler, AZ. Connect with local research sites and explore new treatment options.

9
Active Trials
7
Sponsors
4,898
Enrolling

Recruiting Rheumatoid Arthritis Studies in Chandler

RecruitingChandler, AZNCT05354141

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

To evaluate the safety and efficacy of intravenous (IV) administration of bone marrow mesenchymal stem cell derived extracellular vesicles (EVs), ExoFlo, versus placebo for the treatment of hospitaliz...

970 participants
Direct Biologics, LLC
View Study Details
RecruitingChandler, AZNCT06480383

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

This is a multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo as adjunctive therapy to GAD treatment in ...

705 participants
Intra-Cellular Therapies, Inc.
View Study Details
RecruitingChandler, AZNCT03907046

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atr...

700 participants
Yale University
View Study Details
RecruitingChandler, AZNCT06625060

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity to bright lights and s...

641 participants
Ipsen
View Study Details
RecruitingChandler, AZNCT06880744

A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).This study will evaluate how safe and ef...

530 participants
AbbVie
View Study Details
RecruitingChandler, AZNCT06417775

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, o...

450 participants
AbbVie
View Study Details
RecruitingChandler, AZNCT06568042

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

The purpose of this study is to evaluate how safe and how well a treatment works compared to placebo for people with nerve pain that begins in their feet and moves up the leg to just below the knee. ...

450 participants
Eli Lilly and Company
View Study Details
RecruitingChandler, AZNCT05615844

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and debridement surgeries. Eligible participant...

312 participants
University of Maryland, Baltimore
View Study Details
RecruitingChandler, AZNCT06598943

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severely active ulcerative colitis (UC)....

140 participants
Eli Lilly and Company
View Study Details

About Rheumatoid Arthritis Clinical Trials in Chandler

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.

There are currently 9 rheumatoid arthritis clinical trials recruiting participants in Chandler, AZ. These studies are seeking a combined 4,898 participants. Research is being sponsored by Direct Biologics, LLC, Intra-Cellular Therapies, Inc., Yale University and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Rheumatoid Arthritis Clinical Trials in Chandler — FAQ

Are there rheumatoid arthritis clinical trials in Chandler?

Yes, there are 9 rheumatoid arthritis clinical trials currently recruiting in Chandler, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chandler?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chandler research site will contact you about next steps.

Are clinical trials in Chandler free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chandler studies also compensate for your time and travel.

What rheumatoid arthritis treatments are being tested?

The 9 active trials in Chandler are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.

Data updated March 2, 2026 from ClinicalTrials.gov